Authors/Disclosures
|
Pauline Maillard, PhD
|
Dr. Maillard has nothing to disclose. |
|
Behrang Saminejad, MD
(LVPG Neurology)
|
Dr. Saminejad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus pharmacutical . Dr. Saminejad has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Saminejad has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine . Dr. Saminejad has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Supernus. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Danielle Harvey, PA-C
|
No disclosure on file |
|
Owen T. Carmichael, PhD
(University of California, Davis)
|
No disclosure on file |
|
Bruce R. Reed, PhD
(UC Davis Alzheimer's Disease Ctr)
|
No disclosure on file |
|
Dan M. Mungas, PhD
|
Dr. Mungas has nothing to disclose. |
|
Charles S. DeCarli, MD, FAAN
(UC Davis Health - Dept of NeurologyAlzheimer's Disease Research Center)
|
Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH. |